Identifying novel antimicrobial peptides with therapeutic potential against multidrug-resistant bacteria by using the SPOT synthesis

Mini-Reviews in Organic Chemistry

Volumn 8, Issue 2, 2011, Pages 157-163

  Hilpert, Kai ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Antimicrobial peptide; Drug development; High throughput screening; Host defence peptide; Multidrug resistant; Pseudomonas aeruginosa; QSAR; Spot synthesis

Indexed keywords

BACTERIA; COMPUTATIONAL CHEMISTRY; MOLECULAR GRAPHICS;

ANTIMICROBIAL PEPTIDE; DRUG DEVELOPMENT; HIGH THROUGHPUT SCREENING; HOST DEFENSE; HOST DEFENSE PEPTIDE; MULTIDRUG RESISTANTS; PSEUDOMONAS AERUGINOSA; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; SCREENING METHODS; SPOT SYNTHESIS;

PEPTIDES;

EID: 79953869466     PISSN: 1570193X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157019311795177781     Document Type: Article

References (79)

1. GERMAP, Antibiotika-Resistenz und-Verbrauch. Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH: Rheinbach, Germany, 2008.
2. Rossolini, G. M.; Mantengoli, E. Antimicrobial resistance in Europe and its potential impact on empirical therapy. Clin. Microbiol. Infect. 2008, 14 (Suppl 6), 2-8.
3. Moet, G. J.; Jones, R. N.; Biedenbach, D. J.; Stilwell, M. G.; Fritsche, T. R. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn. Microbiol. Infect. Dis. 2007, 57 (1), 7-13.
4. Rubinchik, E.; Dugourd, D.; Algara, T.; Pasetka, C.; Friedland, H. D. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models. Int. J. Antimicrob. Agents 2009, 34 (5), 457-461.
5. Hancock, R. E.; Lehrer, R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 1998, 16 (2), 82-88.
6. Finking, R.; Marahiel, M. A. Biosynthesis of nonribosomal peptides1. Annu. Rev. Microbiol. 2004, 58, 453-488.
7. Kawabata, S.; Beisel, H. G.; Huber, R.; Bode, W.; Gokudan, S.; Muta, T.; Tsuda, R.; Koori, K.; Kawahara, T.; Seki, N.; Mizunoe, Y.; Wai, S. N.; Iwanaga, S. Role of tachylectins in host defense of the Japanese horseshoe crab Tachypleus tridentatus. Adv. Exp. Med. Biol. 2001, 484, 195-202.
8. Nochi, T.; Kiyono, H. Innate immunity in the mucosal immune system. Curr. Pharm. Des. 2006, 12 (32), 4203-4213.
9. Li, J.; Xu, X.; Xu, C.; Zhou, W.; Zhang, K.; Yu, H.; Zhang, Y.; Zheng, Y.; Rees, H. H.; Lai, R.; Yang, D.; Wu, J. Anti-infection peptidomics of amphibian skin. Mol. Cell. Proteomics 2007, 6 (5), 882-894.
10. Easton, D. M.; Nijnik, A.; Mayer, M. L.; Hancock, R. E. Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 2009, 27 (10), 582-590.
11. Steinstraesser, L.; Kraneburg, U. M.; Hirsch, T.; Kesting, M.; Steinau, H. U.; Jacobsen, F.; Al-Benna, S. Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int. J. Mol. Sci. 2009, 10 (9), 3951-3970.
12. Nijnik, A.; Pistolic, J.; Wyatt, A.; Tam, S.; Hancock, R. E. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. J. Immunol. 2009, 183 (9), 5788-5798.
13. Schiemann, F.; Brandt, E.; Gross, R.; Lindner, B.; Mittelstadt, J.; Sommerhoff, C. P.; Schulmistrat, J.; Petersen, F. The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: counter-regulation by CXCL4. J. Immunol. 2009, 183 (4), 2223-2231.
14. Mookherjee, N.; Hamill, P.; Gardy, J.; Blimkie, D.; Falsafi, R.; Chikatamarla, A.; Arenillas, D. J.; Doria, S.; Kollmann, T. R.; Hancock, R. E. Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells. Mol. Biosyst. 2009, 5 (5), 483-496.
15. Mookherjee, N.; Rehaume, L. M.; Hancock, R. E. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 2007, 11 (8), 993-1004.
16. Mookherjee, N.; Hancock, R. E. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life Sci. 2007, 64 (7-8), 922-933.
17. Brogden, K. A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3 (3), 238-250.
18. Subbalakshmi, C.; Sitaram, N. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett. 1998, 160 (1), 91-96.
19. Hale, J. D.; Hancock, R. E. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti. Infect. Ther. 2007, 5 (6), 951-959.
20. Hancock, R. E. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 2001, 1 (3), 156-164.
21. Boman, H. G. Innate immunity and the normal microflora. Immunol. Rev. 2000, 173, 5-16.
22. Paschke, M. Phage display systems and their applications. Appl. Microbiol. Biotechnol., 2006, 70 (1), 2-11.
23. Yan, X. H.; Xu, Z. R. Ribosome-display technology: applications for directed evolution of functional proteins. Drug Discov. Today 2006, 11 (19-20), 911-916.
24. Pini, A.; Giuliani, A.; Falciani, C.; Runci, Y.; Ricci, C.; Lelli, B.; Malossi, M.; Neri, P.; Rossolini, G. M.; Bracci, L. Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob. Agents Chemother. 2005, 49 (7), 2665-2672.
25. Xie, Q.; Matsunaga, S.; Wen, Z.; Niimi, S.; Kumano, M.; Sakakibara, Y.; Machida, S. In vitro system for high-throughput screening of random peptide libraries for antimicrobial peptides that recognize bacterial membranes. J. Pept. Sci. 2006, 12 (10), 643-652.
26. Houghten, R. A. General-Method for the rapid solid-phase synthesis of large numbers of peptides-specificity of antigen-antibody interaction at the level of individual amino-acids. Proc. Natl. Acad. Sci. USA, 1985, 82 (15), 5131-5135.
27. Pellois, J. P.; Zhou, X. C.; Srivannavit, O.; Zhou, T. C.; Gulari, E.; Gao, X. L. Individually addressable parallel peptide synthesis on microchips. Nature Biotechnol., 2002, 20 (9), 922-926.
28. Geysen, H. M.; Meloen, R. H.; Barteling, S. J. Use of peptide-synthesis to probe viral-antigens for epitopes to a resolution of a single amino-acid. Proc. Natl. Acad. Sci. USA, 1984, 81 (13), 3998-4002.
29. Frank, R. Spot-Synthesis-an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 1992, 48 (42), 9217-9232.
30. Hilpert, K.; Winkler, D. F.; Hancock, R. E. Cellulose-bound peptide arrays: preparation and applications. Biotechnol. Genet. Eng. Rev. 2007, 24, 31-106.
31. Hilpert, K.; Winkler, D. F.; Hancock, R. E. Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat. Protoc. 2007, 2 (6), 1333-1349.
32. Hoffmuller, U.; Knaute, T.; Hahn, M.; Hohne, W.; Schneider-Mergener, J.; Kramer, A. Evolutionary transition pathways for changing peptide ligand specificity and structure. EMBO J. 2000, 19 (18), 4866-4874.
33. Hilpert, K.; Hansen, G.; Wessner, H.; Kuttner, G.; Welfle, K.; Seifert, M.; Hohne, W. Anti-c-myc antibody 9E10: epitope key positions and variability characterized using peptide spot synthesis on cellulose. Protein Eng. 2001, 14 (10), 803-806.
34. Hilpert, K.; Wessner, H.; Schneider-Mergener, J.; Welfle, K.; Misselwitz, R.; Welfle, H.; Hocke, A. C.; Hippenstiel, S.; Hohne, W. Design and characterization of a hybrid miniprotein that specifically inhibits porcine pancreatic elastase. J. Biol. Chem. 2003, 278 (27), 24986-24993.
35. Hilpert, K.; Hancock, R. E. Use of luminescent bacteria for rapid screening and characterization of short cationic antimicrobial peptides synthesized on cellulose using peptide array technology. Nat. Protoc. 2007, 2 (7), 1652-1660.
36. Kamradt, T.; Volkmer-Engert, R. Cross-reactivity of T lymphocytes in infection and autoimmunity. Mol. Divers. 2004, 8 (3), 271-280.
37. Hilpert, K.; Volkmer-Engert, R.; Walter, T.; Hancock, R. E. High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 2005, 23 (8), 1008-1012.
38. Mikut, R.; Hilpert, K. Interpretable features for the activity prediction of short antimicrobial peptides using fuzzy logic. Int. J. Peptide Res. Ther. 2009, 15 (2), 129-137.
39. Mikut, R. Computer-based analysis, visualization, and interpretation of antimicrobial peptide activities. Methods Mol. Biol. 2010, 618, 287-299.
40. Naveh, A.; Potasman, I.; Bassan, H.; Ulitzur, S. A new rapid and sensitive bioluminescence assay for antibiotics that inhibit protein synthesis. J. Appl. Bacteriol. 1984, 56 (3), 457-463.
41. Wheat, P. F.; Spencer, R. C.; Hastings, J. G. A novel luminometer for rapid antimicrobial susceptibility tests on gram-positive cocci by ATP bioluminescence. J. Med. Microbiol. 1989, 29 (4), 277-282.
42. Shawar, R. M.; Humble, D. J.; Van Dalfsen, J. M.; Stover, C. K.; Hickey, M. J.; Steele, S.; Mitscher, L. A.; Baker, W. Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare. Antimicrob. Agents Chemother. 1997, 41 (3), 570-574.
43. Lewenza, S.; Falsafi, R. K.; Winsor, G.; Gooderham, W. J.; McPhee, J. B.; Brinkman, F. S.; Hancock, R. E. Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes. Genome Res. 2005, 15 (4), 583-589.
44. Hilpert, K.; Elliott, M. R.; Volkmer-Engert, R.; Henklein, P.; Donini, O.; Zhou, Q.; Winkler, D. F.; Hancock, R. E. Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem. Biol. 2006, 13 (10), 1101-1107.
45. Wu, M.; Hancock, R. E. Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob. Agents Chemother. 1999, 43 (5), 1274-1276.
46. Hancock, R. E. W.; Hilpert, K. Antimicrobial Peptides. Patent Application PCT/CA2005/001731, WO/2006/050611, 2006.
47. Cherkasov, A.; Hilpert, K.; Jenssen, H.; Fjell, C. D.; Waldbrook, M.; Mullaly, S. C.; Volkmer, R.; Hancock, R. E. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem. Biol. 2009, 4 (1), 65-74.
48. Mikut, R.; Reischl, M.; Ulrich, A. S.; Hilpert, K. In Data-based activity analysis and interpretation of small antibacterial peptides, 18th workshop computational intelligence, Universitaetsverlag Karlsruhe: 2008; pp. 189-203.
49. Karakoc, E.; Sahinalp, S. C.; Cherkasov, A. Comparative QSAR-and fragments distribution analysis of drugs, druglikes, metabolic substances, and antimicrobial compounds. J. Chem. Inf. Model. 2006, 46 (5), 2167-2182.
50. Karakoc, E.; Cherkasov, A.; Sahinalp, S. C. Distance based algorithms for small biomolecule classification and structural similarity search. Bioinformatics 2006, 22 (14), e243-51.
51. Fjell, C. D.; Jenssen, H.; Hilpert, K.; Cheung, W. A.; Pante, N.; Hancock, R. E.; Cherkasov, A. Identification of novel antibacterial peptides by chemoinformatics and machine learning. J. Med. Chem. 2009, 52 (7), 2006-2015.
52. Hilpert, K.; Elliott, M.; Jenssen, H.; Kindrachuk, J.; Fjell, C. D.; Korner, J.; Winkler, D. F.; Weaver, L. L.; Henklein, P.; Ulrich, A. S.; Chiang, S. H.; Farmer, S. W.; Pante, N.; Volkmer, R.; Hancock, R. E. Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem. Biol. 2009, 16 (1), 58-69.
53. Rozek, A.; Friedrich, C. L.; Hancock, R. E. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 2000, 39 (51), 15765-15774.
54. Lee, S. A.; Kim, Y. K.; Lim, S. S.; Zhu, W. L.; Ko, H.; Shin, S. Y.; Hahm, K. S.; Kim, Y. Solution structure and cell selectivity of piscidin 1 and its analogues. Biochemistry 2007, 46 (12), 3653-3663.
55. Shenkarev, Z. O.; Nadezhdin, K. D.; Sobol, V. A.; Sobol, A. G.; Skjeldal, L.; Arseniev, A. S. Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle. FEBS J. 2006, 273 (12), 2658-2672.
56. Turner, J.; Cho, Y.; Dinh, N. N.; Waring, A. J.; Lehrer, R. I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 1998, 42 (9), 2206-2214.
57. Mandard, N.; Sy, D.; Maufrais, C.; Bonmatin, J. M.; Bulet, P.; Hetru, C.; Vovelle, F. Androctonin, a novel antimicrobial peptide from scorpion Androctonus australis: solution structure and molecular dynamics simulations in the presence of a lipid monolayer. J. Biomol. Struct. Dyn. 1999, 17 (2), 367-380.
58. Casteels-Josson, K.; Capaci, T.; Casteels, P.; Tempst, P. Apidaecin multipeptide precursor structure: a putative mechanism for amplification of the insect antibacterial response. EMBO J. 1993, 12 (4), 1569-1578.
59. Rozek, T.; Wegener, K. L.; Bowie, J. H.; Olver, I. N.; Carver, J. A.; Wallace, J. C.; Tyler, M. J. The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. Eur. J. Biochem. 2000, 267 (17), 5330-5341.
60. Csordas, A.; Michl, H. Isolation and structural resolution of a haemolytically active polypeptide from the immune secretion of a European toad. Monatsh. Chem. 1970, 101, 182-189.
61. Moore, A. J.; Beazley, W. D.; Bibby, M. C.; Devine, D. A. Antimicrobial activity of cecropins. J. Antimicrob. Chemother. 1996, 37 (6), 1077-1089.
62. Sipos, D.; Andersson, M.; Ehrenberg, A. The structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR. Eur. J. Biochem. 1992, 209 (1), 163-169.
63. Lee, I. H.; Zhao, C.; Cho, Y.; Harwig, S. S.; Cooper, E. L.; Lehrer, R. I. Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes. FEBS Lett. 1997, 400 (2), 158-162.
64. Wang, H.; Ng, T. B. Ginkbilobin, a novel antifungal protein from Ginkgo biloba seeds with sequence similarity to embryo-abundant protein. Biochem. Biophys. Res. Commun. 2000, 279 (2), 407-411.
65. Lee, D. L.; Hodges, R. S. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S. Biopolymers 2003, 71 (1), 28-48.
66. Wadhwani, P.; Afonin, S.; Ieronimo, M.; Buerck, J.; Ulrich, A. S. Optimized protocol for synthesis of cyclic gramicidin S: starting amino acid is key to high yield. J. Org. Chem. 2006, 71 (1), 55-61.
67. Ryge, T. S.; Doisy, X.; Ifrah, D.; Olsen, J. E.; Hansen, P. R. New indolicidin analogues with potent antibacterial activity. J. Pept. Res. 2004, 64 (5), 171-185.
68. Selsted, M. E.; Novotny, M. J.; Morris, W. L.; Tang, Y. Q.; Smith, W.; Cullor, J. S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 1992, 267 (7), 4292-4295.
69. Vogel, H. J.; Schibli, D. J.; Jing, W.; Lohmeier-Vogel, E. M.; Epand, R. F.; Epand, R. M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan-and arginine-containing peptides. Biochem. Cell Biol. 2002, 80 (1), 49-63.
70. Travis, S. M.; Anderson, N. N.; Forsyth, W. R.; Espiritu, C.; Conway, B. D.; Greenberg, E. P.; McCray, P. B., Jr.; Lehrer, R. I.; Welsh, M. J.; Tack, B. F. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 2000, 68 (5), 2748-2755.
71. Baker, M. A.; Maloy, W. L.; Zasloff, M.; Jacob, L. S. Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res. 1993, 53 (13), 3052-3057.
72. Kreil, G. Structure of melittin isolated from two species of honey bees. FEBS Lett. 1973, 33, 241-244.
73. Cole, A. M.; Weis, P.; Diamond, G. Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J. Biol. Chem. 1997, 272 (18), 12008-12013.
74. Zanetti, M.; Storici, P.; Tossi, A.; Scocchi, M.; Gennaro, R. Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells. J. Biol. Chem. 1994, 269 (11), 7855-7858.
75. Regna, P. P.; Solomons, I. A.; Forscher, B.K.; Timreck, A.E. Chemical studies on polymyxin B. J. Clin. Invest. 1949, 28 (5 Pt. 1), 1022-1027.
76. Laederach, A.; Andreotti, A. H.; Fulton, D. B. Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives. Biochemistry 2002, 41 (41), 12359-12368.
77. Simmaco, M.; Mignogna, G.; Canofeni, S.; Miele, R.; Mangoni, M. L.; Barra, D. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur. J. Biochem. 1996, 242 (3), 788-792.
78. Chen, W.; Yang, X.; Zhai, L.; Lu, Z.; Liu, J.; Yu, H. Antimicrobial peptides from the venoms of Vespa bicolor Fabricius. Peptides 2008, 29 (11), 1887-1892.
79. Lin, K. F.; Lee, T. R.; Tsai, P. H.; Hsu, M. P.; Chen, C. S.; Lyu, P. C. Structure-based protein engineering for alpha-amylase inhibitory activity of plant defensin. Proteins 2007, 68 (2), 530-540.